Andrew A. Dahl, MD, is a board-certified ophthalmologist. Dr. Dahl's educational background includes a BA with Honors and Distinction from Wesleyan University, Middletown, CT, and an MD from Cornell University, where he was selected for Alpha Omega Alpha, the national medical honor society. He had an internal medical internship at the New York Hospital/Cornell Medical Center.
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
The most important method of preventing eye disease related to diabetes is to maintain strict control of blood sugar. High blood pressure and high lipid or
cholesterol levels must also be treated to decrease damage to the blood vessels within the eye.
The most common problem with the most potential to cause blindness is diabetic retinopathy.
Currently, effective oral medications or eye drops do not exist to directly treat diabetic retinopathy, and surgery (for
example, laser) is the treatment of choice.
Investigational drugs by injection around the eye or taken orally are currently being studied to determine their effectiveness in preventing and treating diabetic retinopathy.
Depending on the type of glaucoma, treatment may include medications and/or surgery. Intraocular pressure usually can be lowered using different medications in the form of eyedrops. Some oral medications may also be prescribed, but their use is rare.
Various types of eyedrops are commonly used, and more than one type of eyedrop is often needed to lower intraocular pressure.
Beta-adrenergic blocking agents, prostaglandins, carbonic anhydrase inhibitors, alpha-adrenergic agents, miotics, and sympathomimetic drugs are examples of eyedrop medications used to treat glaucoma. All of these medications lower intraocular pressure.
Prostaglandin eyedrops include latanoprost (Xalatan),
travoprost (Travatan), and